General presentation of Novacyt
Let us now take a few moments to examine the Novacyt Company’s activities and its major sources of revenue so you are better able to understand this company’s possibilities for development and growth in the coming years.
The Novacyt Group is a French medical company specialised in the development, production and sale of in-vitro and molecular diagnostic products destined for the oncology, microbiology, haematology and serology sectors.
To better understand the activities of the Novacyt Group it is possible to divide them into different sectors according to the turnover that each activity generates and how:
- Firstly, the major activities of the Novacyt Company relate to the development of laboratory diagnostic services and solutions which account for 51.8% of this company’s turnover. As part of these activities the group has developed and manufactures reagents and kits for bacteria and blood analyses.
- The rest of the group’s turnover, which accounts for 48.2%, is generated by the manufacture and sale of molecular testing kits through its subsidiary Primedesign. These kits are destined for laboratories.
It can also be advantageous to know the geographical distribution of the Novacyt group’s activities. In fact, 42% of this company’s turnover is generated in Europe, 19.5% in Pacific Asia, 20.4% in America, 10.5% in the Middle East and 7.6% in Africa.
It should also be noted that the Novacyt Group sold its sales activities in cytology solutions, NOVAprep, in 2019.
67% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on eToro